HARMONISED APPROACH TO EARLY FEASIBILITY STUDIES FOR MEDICAL DEVICES IN THE EUROPEAN UNION

Informazioni relative al progetto

HEU-EFS

ID dell’accordo di sovvenzione: 101112185

DOI

10.3030/101112185

Data della firma CE 25 Ottobre 2023

Data di avvio 1 Ottobre 2023

Data di completamento 30 Settembre 2027

Finanziato da

• Health

Costo totale

€ 19 008 438,75

Contributo UE

€ 10 532 197,50

Coordinato da

UNIVERSITA COMMERCIALE LUIGI BOCCONI
Italy

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (7)

EU regulatory framework and international standards

Research report summarizing the current EU regulatory framework for clinical evidence generation for MDs and DHTs and relations with the future EU EFS Program.

Professional and organizational characteristics of competent authorities

Report on CAs’ professional and organizational capacities and gaps to fulfil for a successful EU EFS program.

Research report summarizing the current EU regulatory framework for clinical evidence generation for MDs and DHTs and relations with the future EU EFS Program.
Characteristics and state of play of EFS

Research report summarizing the findings of the empirical investigation on individual EFS impact on lifecycle evidence generation and MDs safety.

Recommendations for HEU-EFS on state of play of regulatory framework and institutional and organizational characteristics of EU competent authorities

Paper summarizing the main findings on the state of play of the regulatory framework and organization of clinical evidence generation programs in the EU and recommendations for the development of the EU EFS methodology (open access).

Characteristics, gaps, and best practices of premarket programs

Research report summarizing the findings of the systematic review on premarketprograms, including finding from surveys and interviews.

Eligibility criteria and patient contribution to EFS

Research report summarizing recommendations regarding EU EFS Program eligibility criteria and patients’ role and contribution to EFS.

Websites, patent fillings, videos etc. (2)

HEU-EFS Online Portal

Freely accessible HEU-EFS online portal.

Educational content for research and analysis activities

Educational content (e.g. live and pre-recorded training sessions, short video tutorials, executive summaries, informative documents) for the stakeholders involved in the research and analysis activities such as surveys, focus groups or interviews.

Pubblicazioni

Conference proceedings (3)

MT58 Use of Early Feasibility Studies to Inform Development of Medical Devices

Autori: C Federici, FL Zurlo, R Tarricone, G Callea
Pubblicato in: Value in Health, Numero 27, 2024, ISSN 1098-3015
Editore: Elsevier BV
DOI: 10.1016/j.jval.2024.10.2528

HPR67 Global Assessment of Pre-Market Approval Pathways for Medical Devices: Highlighting the Need for Harmonization Across 55 Jurisdictions

Autori: FB Malandrini, G Callea, R Tarricone, M Kerstan, L. Sampietro-Colom, A Valledor, A Balsamo, D Catania, S Vainieri, M Tocchi, O Tangila Kayembe, T Melvin, A Poulsson, S Kuhn, A Rappagliosi, P Auclair, M Gielkens, C Santin, R Roijers, L Kvistgaard Jensen
Pubblicato in: Value in Health, Numero 27, 2024, ISSN 1098-3015
Editore: Elsevier BV
DOI: 10.1016/j.jval.2024.10.1494

HPR98 The EU Regulatory Framework for Medical Device Early Feasibility Studies: What Do We Know to Date?

Autori: T Melvin, N Martelli, S Kuhn, O Tangila Kayembe, I Michaelis, M Peseke, A McDonnell, F Murphy, M Geraghty, H Banks, G Callea, R Tarricone
Pubblicato in: Value in Health, Numero 27, 2024, ISSN 1098-3015
Editore: Elsevier BV
DOI: 10.1016/j.jval.2024.10.1524